FDA Approved: BREO ELLIPTA — Supplemental Application (GlaxoSmithKline LLC)

View source ↗

Summary

FDA approved a supplemental application for BREO ELLIPTA submitted by GlaxoSmithKline. The approval pertains to changes to the product's labeling as part of the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• BREO ELLIPTA (fluticasone furoate and vilanterol trifenatate)

Snippet

SUPPL AP for BREO ELLIPTA (FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE)